Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Freeman

Showing results (71-80 of 244) with videos related to

Pageof 25
Sort By:
European Urology|June 1, 2021
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical RiskPranav Satish, Benjamin Simpson, Alex Freeman, et al.
The Journal of Pathology. Clinical Research|January 26, 2019
Training and accreditation standards for pathologists undertaking clinical trial workGabrielle Rees, Manuel Salto-Tellez, Jessica L Lee, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 20, 2004
Differential expression of CD44 during human prostate epithelial cell differentiationTahirah N Alam, Michael J O'Hare, István Laczkó, et al.
Urologic Oncology|September 24, 2013
The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?Mohamed Abd-Alazeez, Hashim U Ahmed, Manit Arya, et al.
The Journal of Urology|July 30, 2013
The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapismEvangelos Zacharakis, Amr Abdel Raheem, Alex Freeman, et al.
The Journal of Urology|October 5, 2016
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate CancerMassimo Valerio, Louise Dickinson, Afia Ali, et al.
BMJ Open|October 27, 2018
Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UKEdward James Bass, Alex Freeman, Charles Jameson, et al.
Urology|August 9, 2015
What Burden of Prostate Cancer Can Radiologists Rule Out on Multiparametric Magnetic Resonance Imaging? A Sensitivity Analysis Based on Varying the Target Condition in Template Prostate Mapping BiopsiesEleni Anastasiadis, Susan C Charman, Nimalan Arumainayagam, et al.
Urologic Oncology|September 25, 2016
Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancerLouise Dickinson, Hashim U Ahmed, Richard G Hindley, et al.
BMJ Open|October 14, 2017
A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocolVeeru Kasivisvanathan, Fatima Jichi, Laurence Klotz, et al.
Pageof 25

Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
European Urology|June 1, 2021
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical RiskPranav Satish, Benjamin Simpson, Alex Freeman, et al.
The Journal of Pathology. Clinical Research|January 26, 2019
Training and accreditation standards for pathologists undertaking clinical trial workGabrielle Rees, Manuel Salto-Tellez, Jessica L Lee, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 20, 2004
Differential expression of CD44 during human prostate epithelial cell differentiationTahirah N Alam, Michael J O'Hare, István Laczkó, et al.
Urologic Oncology|September 24, 2013
The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?Mohamed Abd-Alazeez, Hashim U Ahmed, Manit Arya, et al.
The Journal of Urology|July 30, 2013
The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapismEvangelos Zacharakis, Amr Abdel Raheem, Alex Freeman, et al.
The Journal of Urology|October 5, 2016
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate CancerMassimo Valerio, Louise Dickinson, Afia Ali, et al.
BMJ Open|October 27, 2018
Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UKEdward James Bass, Alex Freeman, Charles Jameson, et al.
Urology|August 9, 2015
What Burden of Prostate Cancer Can Radiologists Rule Out on Multiparametric Magnetic Resonance Imaging? A Sensitivity Analysis Based on Varying the Target Condition in Template Prostate Mapping BiopsiesEleni Anastasiadis, Susan C Charman, Nimalan Arumainayagam, et al.
Urologic Oncology|September 25, 2016
Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancerLouise Dickinson, Hashim U Ahmed, Richard G Hindley, et al.
BMJ Open|October 14, 2017
A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocolVeeru Kasivisvanathan, Fatima Jichi, Laurence Klotz, et al.
Pageof 25